Immuno-humoral Rejection Markers in Pulmonary Transplant (RHUM-TP)

H

Hopital Foch

Status

Completed

Conditions

Lung Transplant

Treatments

Biological: Blood test for detecting the circulatory anti-HLA antibodies by ELISA and LUMINEX tests

Study type

Interventional

Funder types

Other

Identifiers

NCT01791166
2010/49

Details and patient eligibility

About

Open multicentric prospective study performed on pulmonary transplanted patients to detect the values of different diagnostic markers for immuno- humoral reaction and their roles in the humoral rejection for those patients.

Enrollment

53 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Both genders, more than 18 years of age.
  • Patients with or without Cystic fibrosis
  • Patients with no previous unilateral or bilateral pulmonary transplant or cardiopulmonary transplant
  • Patients with no current other disease can affect, in short term, the process or prognosis of the transplant
  • Patients had given his agreement to be enrolled in the study

Exclusion criteria

  • Patient less than 18 year-old
  • Patient had previous organ transplant
  • Pregnant and/or lactating women
  • Female subject in reproductive age does not use effective contraceptive methode
  • Alcoholisms or neuropsychosis, conditions that affect the good comprehension of the study

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

53 participants in 1 patient group

Pulmonary transplant
Experimental group
Treatment:
Biological: Blood test for detecting the circulatory anti-HLA antibodies by ELISA and LUMINEX tests

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems